publication date: Feb. 15, 2019

In Brief

Caryn Lerman named director at USC Norris Comprehensive Cancer Center

Caryn Lerman was named director at USC Norris Comprehensive Cancer Center, effective March 15. 

She also will hold the position of professor of psychiatry and the behavioral sciences at the Keck School of Medicine of USC.

Lerman becomes the only behavioral scientist to lead an NCI-designated cancer center.

Lerman comes to USC from the Perelman School of Medicine at the University of Pennsylvania, where she serves as the John H. Glick Professor for Cancer Research and vice dean for strategic initiatives.

“I’m honored to return to USC and the Trojan family to lead such an outstanding cancer center with the mission of reducing the burden of cancer in Los Angeles and beyond,” said Lerman, who received a master’s degree in psychology and a doctoral degree in clinical psychology, both from USC. “We are at a pivotal moment in cancer research where remarkable scientific and clinical breakthroughs are changing the course of how we prevent, detect and treat this disease. With the exceptional talent, dedicated clinicians, entrepreneurial mindset and culture of inclusion throughout USC Norris Comprehensive Cancer Center, there is no limit to what we can accomplish together.”

Announcing the appointment, Laura Mosqueda, dean of the Keck School, noted Lerman’s experience leading cancer centers and programs, as well as her nationally recognized cancer prevention research that has spanned the fields of neuroscience, pharmacology, genetics and behavioral science.

Lerman was among the first to publish evidence for the genetic basis of cancer risk behaviors, including pioneering work on the genetic influences on tobacco use that helped shape tobacco dependence treatment.


Continue reading Caryn Lerman named director at USC Norris Comprehensive Cancer Center

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2021 The Cancer Letter Inc.